Forbes October 21, 2020
Our biotech industry is working at unprecedented speeds to bring a COVID-19 vaccine to market; rather than unprecedented, these speeds should be the new norm.
“You never let a serious crisis go to waste — it’s an opportunity to do things you think you could not do before.” — Rahm Immanuel
The arrival of COVID-19 has achieved something no other disease before it has — the FDA and drug companies are working closely to accelerate the speed of vaccine and drug development. And while COVID-19 has a much bigger societal impact, the stark reality is that other diseases like cancer or cystic fibrosis are always life-or-death for some part of the population
Our current crisis has shown that when...